Adenosine Altamedics 30 mg/10 ml solution for infusion Malta - English - Medicines Authority

adenosine altamedics 30 mg/10 ml solution for infusion

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - solution for infusion - adenosine 3 mg/ml - cardiac therapy

Adenocor New Zealand - English - Medsafe (Medicines Safety Authority)

adenocor

pharmacy retailing (nz) ltd t/a healthcare logistics - adenosine 3 mg/ml (candida utilis lysed to get rna,then hydrolysed to adenosine);   - solution for injection - 6 mg/2ml - active: adenosine 3 mg/ml (candida utilis lysed to get rna,then hydrolysed to adenosine)   excipient: sodium chloride water for injection - adenocor is indicated for rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome), and as an aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias, and in sensitisation of intracavity electrophysiological investigations.

Adenocor 3 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

adenocor 3 mg/ml solution for injection

sanofi-aventis ireland limited t/a sanofi - adenosine - solution for injection - 3 milligram(s)/millilitre - other cardiac preparations; adenosine

Adenosine 3mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 3mg/ml solution for injection

wockhardt uk limited - adenosine - solution for injection - 3 milligram(s)/millilitre - other cardiac preparations; adenosine

Adenosine 30mg/10ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 30mg/10ml solution for infusion

wockhardt uk limited - adenosine - solution for infusion - 30 milligram/ 10 millilitre - other cardiac preparations; adenosine

Adsine New Zealand - English - Medsafe (Medicines Safety Authority)

adsine

baxter healthcare ltd - adenosine 3 mg/ml;  ;   - solution for injection - 6 mg/2ml - active: adenosine 3 mg/ml     excipient: sodium chloride water for injection - therapeutic indications rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome). diagnostic indications aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias. although adenosine-claris 6 mg/2 ml is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. sensitisation of intra-cavitary electrophysiological investigations.

Adenosine 3 mg/ml solution for injection in pre-filled syringe Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 3 mg/ml solution for injection in pre-filled syringe

fresenius kabi deutschland gmbh - adenosine - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - other cardiac preparations; adenosine